Induction-concurrent Versus Concurrent-Adjuvant Chemoradiotherapy in Patients with High-Risk N2–3 Nasopharyngeal Carcinoma: an Open-Label, Randomised, Controlled, Phase 3 Trial.
JOURNAL OF CLINICAL ONCOLOGY(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要